Immune responses against the hepatitis C virus and the outcome of therapy

Hepatitis C Virus Disease: Immunobiology and Clinical Applications

Volumn , Issue , 2008, Pages 71-86

  Klenerman, Paul ^a   Barnes, Eleanor ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84900245794     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-0-387-71376-2_4     Document Type: Chapter

References (60)

1. Accapezzato, D., Francavilla, V., Paroli, M., Casciaro, M., Chircu, L. V., Cividini, A., Abrignani, S., Mondelli M. U., Barnaba, V. (2004). Hepatic expansion of a virus-specific regulatory CD8 (+) T cell population in chronic hepatitis C virus infection. Journal of Clinical Investigation, 113:963-972.
2. Barber, D. L., Wherry, E. J., Masopust, D., Zhu, B., Allison, J. P., Sharpe, A. H., Freeman, G. H., Ahmed, R. (2006). Restoring function in exhausted CD8 T cells during chronic viral infection. Nature, 439:682-687.
3. Barnes, E., Harcourt, G., Brown, O., Lucas, M., Phillips, R., Dusheiko, G., Klenerman, P. (2002). The dynamics of T-lymphocyte responses during combination therapy for chronic hepatitis C virus infection. Hepatology, 36:743-754.
4. Barnes, E., Salio, M., Cerundolo, V., Medlin, J., Murphy, S., Dusheiko, G., Klenerman, P. (2004). Impact of alpha interferon and ribavirin on the function of maturing dendritic cells. Antimicrobial Agents & Chemotherapy, 48:3382-3389.
5. Boettler, T., Spangenberg, H. C., Neumann-Haefelin, C., Panther, E., Urbani, S., Ferrari, C., Blum, H. E., Von Weizsacker, F., Thimme, R. (2005). T cells with a CD4+CD25+ regulatory phenotype suppress in vitro proliferation of virus-specific CD8+ T cells during chronic hepatitis C virus infection. Journal of Virology, 79:7860-7867.
6. Bowen, D. G., Walker, C. M. (2005). Mutational escape from CD8+ T cell immunity: HCV evolution, from chimpanzees to man. Journal of Experimental Medicine, 201:1709-1714.
7. Brinkmann, V., Geiger, T., Alkan, S., Heusser, C. H. (1993). Interferon alpha increases the frequency of interferon gamma-producing human CD4+ T cells. Journal of Experimental Medicine, 178:1655-1663.
8. Brooks, D. G., Trifilo, M. J., Edelmann, K. H., Teyton, L., McGavern, L. B., Oldstone, M. B. (2006). Interleukin-10 determines viral clearance or persistence in vivo. Nature Medicine, 12:1301-1309.
9. Cooper, S., Erickson, A. L., Adams, E. J., Kansopon, J., Weiner, A. J., Chien, D. Y., Houghton, M., Parham, P., Walker, C. M. (1999). Analysis of a successful immune response against hepatitis C virus. Immunity, 10:439-449.
10. Cox, A. L., Mosbruger, T., Lauer, G. M., Pardoll, D., Thomas, D. L., Ray, S. C. (2005a). Comprehensive analyses of CD8+ T cell responses during longitudinal study of acute human hepatitis C. Hepatology, 42:104-412.
11. Cox, A. L., Mosbruger, T., Mao, Q., Liu, Z., Wang, X. H., Yang, H. C., Sidney, J., Sette, A., Pardoll, D., Thomas, D. L., Ray, S. C. (2005b). Cellular immune selection with hepatitis C virus persistence in humans. Journal of Experimental Medicine, 201:1741-1752.
12. Cramp, M. E., Rossol, S., Chokshi, S., Carucci, P., Williams, R., Naoumov, N. V. (2000). Hepatitis C virus-specific T-cell reactivity during interferon and ribavirin treatment in chronic hepatitis C. Gastroenterology, 118:346-355.
13. Day, C. L., Kaufmann, D. E., Kiepiela, P., Brown, J. A., Moodley, E. S., Reddy, S., Mackey, E. W., Miller, J. D., Leslie, A. J., De Pierres, C., Mncube, Z., Duraiswamy, J., Zhu, B., Eichbaum, Q., Altfeld, M., Wherry, E. J., Coovadia, H. M., Goulder, P. J., Klenerman, P., Ahmed, R., Freeman, G. J., Walker, B. D. (2006). PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression. Nature, 443:350-354.
14. Day, C. L., Lauer, G. M., Robbins, G. K., McGovern, B., Wurcel, A. G., Gandhi, R. T., Chung, R. T., Walker, B. D. (2002). Broad specificity of virus-specific CD4+ T-helper-cell responses in resolved hepatitis C virus infection. Journal of Virology, 76:12584-12595.
15. Diepolder, H., Zachoval, R., Hoffman, R., Wierenga, E., Santorino, T., Jung, M., Eichenlaub, D., Pape, G. (1995). Possible mechanism involving T lymphocyte response to NS3 in viral clearance in acute HCV infection. Lancet, 346:1006-1007.
16. Erickson, A. L., Kimura, Y., Igarashi, S., Eichelberger, J., Houghton, M., Sidney, J., McKinney, D., Sette, A., Hughes, A. L., Walker, C. M. (2001). The outcome of hepatitis C virus infection is predicted by escape mutations in epitopes targeted by cytotoxic T lymphocytes. Immunity, 15:883-895.
17. Farci, P., Shimoda, A., Coiana, A., Diaz, G., Peddis, G., Melpolder, J. C., Strazzera, A., Chien, A. Y., Munoz, S. J., Balestrieri, A., Purcell, R. H., Alter, H. J. (2000). The outcome of acute hepatitis C predicted by the evolution of the viral quasispecies. Science, 288:339-344.
18. Fehervari, Z., Sakaguchi, S. (2004). Development and function of CD25+CD4+ regulatory T cells. Current Opinion in Immunology, 16:203-208.
19. Gaudieri, S., Rauch, A., Park, L. P., Freitas, E., Herrmann, S., Jeffrey, G., Cheng, W., Pfafferott, K., Naidoo, K., Chapman, R., Battegay, M., Weber, R., Telenti, A., Furrer, H., James, I., Lucas, M., Mallal, M. S. (2006). Evidence of viral adaptation to HLA class I-restricted immune pressure in chronic hepatitis C virus infection. Journal of Virology, 80:11094-11104.
20. Gerlach, J., Diepolder, H., Jung, M.-C., Gruener, N., Schraut, W., Zachoval, R., Hoffman, R., Schirren, C., Santantonio, T., Pape, G. (1999). Recurrence of HCV after loss of virus specific CD4+ T cell response in acute hepatitis C. Gastroenterology, 117:933-941.
21. Godkin, A. (2001). Characterization of novel HLA-DR11-restricted HCV epitopes reveals both qualitative and quantitative differences in HCV-specific CD4+ T cell responses in chronically infected and non-viremic patients. European Journal of Immunology, 31:1438-1446.
22. Grabowska, A. M., Lechner, F., Klenerman, P., Tighe, P. J., Ryder, S., Ball, J. K., Thomson, J. K., Irving, W. L., Robins, R. A. (2001). Direct ex vivo comparison of the breadth and specificity of the T cells in the liver and peripheral blood of patients with chronic HCV infection. European Journal of Immunology, 31:2388-2394.
23. Grakoui, A., Shoukry, N. H., Woollard, D. J., Han, J. H., Hanson, H. L., Ghrayeb, J., Murthy, K. K., Rice, C. M., Walker, C. M. (2003). HCV persistence and immune evasion in the absence of memory T cell help. Science, 302:659-662.
24. Gruener, N. H., Lechner, F., Jung, M. C., Diepolder, H., Gerlach, T., Lauer, G., Walker, B., Sullivan, J., Phillips, R., Pape, G. R., Klenerman, P. (2001). Sustained dysfunction of antiviral CD8+ T lymphocytes after infection with hepatitis C virus. Journal of Virology, 75:5550-5558.
25. Harcourt, G., Gomperts, E., Donfield, S., Klenerman, P. (2006). Diminished frequency of hepatitis C virus specific interferon {gamma} secreting CD4+ T cells in human immunodeficiency virus/hepatitis C virus coinfected patients. Gut, 55:1484-1487.
26. Harcourt, G., Hellier, S., Bunce, M., Satsangi, J., Collier, J., Chapman, R., Phillips, R., Klenerman, P. (2001). Effect of HLA class II genotype on T helper lymphocyte responses and viral control in hepatitis C virus infection. Journal of Viral Hepatitis, 8:174-179.
27. Harcourt, G. C., Lucas, M., Godkin, A. J., Kantzanou, M., Phillips, R. E., Klenerman, P. (2003). Evidence for lack of cross-genotype protection of CD4+ T cell responses during chronic hepatitis C virus infection. Clinical & Experimental Immunology, 131:122-129.
28. Harcourt, G. C., Lucas, M., Sheridan, I., Barnes, E., Phillips, R., Klenerman, P. (2004). Longitudinal mapping of protective CD4+ T cell responses against HCV: analysis of fluctuating dominant and subdominant HLA-DR11 restricted epitopes. Journal of Viral Hepatitis, 11:324-331.
29. He, X.-S., Rehermann, B., Lopez-Labrador, F., Boisvert, J., Cheung, R., Mumm, J., Wedermeyer, H., Berenguer, M., Wright, T., Davis, M. (1999). Quantitative analysis of HCV-specific CD8+ T cells in peripheral blood and liver using peptide-MHC tetramers. Proceedings of the National Academy of Sciences (USA), 96:5692-5697.
30. Kamal, S. M., Fehr, J., Roesler, B., Peters, T., Rasenack, J. W. (2002). Peginterferon alone or with ribavirin enhances HCV-specific CD4 T-helper 1 responses in patients with chronic hepatitis C. Gastroenterology, 123:1070-1083.
31. Kamal, S. M., Ismail, A., Graham, C. S., He, W., Rasenack, J. W., Peters, T., Tawil, A. A., Fehr, J. J., Khalifa Kel, S., Madwar, M. M., Koziel, M. J. (2004). Pegylated interferon alpha therapy in acute hepatitis C: relation to hepatitis C virus-specific T cell response kinetics. Hepatology, 39:1721-1731.
32. Kim, A. Y., Lauer, G. M., Ouchi, K., Addo, M. M., Lucas, M., Schulze Zur Wiesch, J., Timm, J., Boczanowski, M., Duncan, J. E., Wurcel, A. G., Casson, D., Chung, R. T., Draenert, R., Klenerman, P., Walker, B. D. (2005). The magnitude and breadth of hepatitis C virus-specific CD8+ T cells depend on absolute CD4+ T-cell count in individuals coinfected with HIV-1. Blood, 105:1170-1178.
33. Klenerman, P., Hill, A. (2005). T cells and viral persistence: lessons from diverse infections. Nature Immunology, 6:873-879.
34. Koziel, M., Walker, B. (1997). Characteristics of the intrahepatic CTL response in chronic HCV infection. Springer Seminars in Immunopathology, 19:69-83.
35. Lauer, G., Barnes, E., Lucas, M., Timm, J., Ouchi, K., Kim, A., Day, C., Robbins, G., Casson, D., Reiser, M., Dusheiko, G., Allen, T., Chung, R., Walker, B., Klenerman, P. (2004). High resolution analysis of cellular immune responses in resolved and persistent hepatitis C virus infection. Gastroenterology, 127:924-936.
36. Lauer, G. M., Lucas, M., Timm, J., Ouchi, K., Kim, A. Y., Day, C. L., Schulze Zur Wiesch, J., Paranhos-Baccala, G., Sheridan, I., Casson, D. R., Reiser, M., Gandhi, R. T., Li, B., Allen, T. M., Chung, R. T., Klenerman, P., Walker, B. D. (2005). Full-breadth analysis of CD8+ T-cell responses in acute hepatitis C virus infection and early therapy. Journal of Virology, 79:12979-12988.
37. Le Bon, A., Etchart, N., Rossmann, C., Ashton, M., Hou, S., Gewert, D., Borrow, P., Tough, D. F. (2003). Cross-priming of CD8 (+) T cells stimulated by virus-induced type I interferon. Nature Immunology 4:1009-1015.
38. Lechner, F., Gruener, N., Urbani, S., Uggeri, J., Santantonio, T., Cerny, A., Phillips, R., Ferrari, C., Pape, G., Klenerman, P. (2000a). CTL responses are induced during acute HCV infection but are not sustained. European Journal of Immunology, 30:2479-2487.
39. Lechner, F., Wong, D. K., Dunbar, P. R., Chapman, R., Chung, R. T., Dohrenwend, P., Robbins, G., Phillips, R., Klenerman, P., Walker, B. D. (2000b). Analysis of successful immune responses in persons infected with hepatitis C virus. Journal of Experimental Medicine, 191:1499-1512.
40. Luft, T., Pang, K. C., Thomas, E., Hertzog, P., Hart, D. N., Trapani, J., Cebon, J. (1998). Type I IFNs enhance the terminal differentiation of dendritic cells. Journal of Immunology, 161:1947-19453.
41. Marinho, R. T., Pinto, R., Santos, M. L., Lobos, I. V., Moura, M. C. (2004). Effects of interferon and ribavirin combination therapy on CD4+ proliferation, lymphocyte activation, and Th1 and Th2 cytokine profiles in chronic hepatitis C. Journal of Viral Hepatitis, 11:206-216.
42. Martin, J., Navas, S., Quiroga, J. A., Pardo, M., Carreno, V. (1998). Effects of the ribavirininterferon alpha combination on cultured peripheral blood mononuclear cells from chronic hepatitis C patients. Cytokine, 10:635-644.
43. Missale, G., Bertoni, R., Lamonaca, V., Valli, A., Massari, M., Mori, C., Rumi, M., Houghton, M., Fiaccadori, F., Ferrari, C. (1996). Different clinical behaviours of acute HCV infection are associated with different vigor of the anti-viral T cell response. Journal of Clinical Investigation, 98:706-714.
44. Moskophidis, D., Laine, E., Zinkernagel, R. M. (1993). Peripheral clonal deletion of antiviral memory CD8+ T cells. European Journal of Immunology, 23:3306-3311.
45. Plosker, G. L., Keating, G. M. (2004). Peginterferon-alpha-2a (40kD) plus ribavirin: a review of its use in hepatitis C virus and HIV co-infection. Drugs, 64:2823-2843.
46. Rahman, F., Heller, T., Sobao, Y., Mizukoshi, E., Nascimbeni, M., Alter, H., Herrine, S., Hoofnagle, J., Liang, T. J., Rehermann, B. (2004). Effects of antiviral therapy on the cellular immune response in acute hepatitis C. Hepatology, 40:87-97.
47. Rushbrook, S. M., Ward, S. M., Unitt, E., Vowler, S. L., Lucas, M., Klenerman, P., Alexander, G. J. (2005). Regulatory T cells suppress in vitro proliferation of virus-specific CD8+ T cells during persistent hepatitis C virus infection. Journal of Virology, 79:7852-7859.
48. Santini, S. M., Lapenta, C., Logozzi, M., Parlato, S., Spada, M., Di Pucchio, T., Belardelli, F. (2000). Type I interferon as a powerful adjuvant for monocyte-derived dendritic cell development and activity in vitro and in Hu-PBL-SCID mice. Journal of Experimental Medicine, 191:1777-1788.
49. Semmo, N., Day, C. L., Ward, S. M., Lucas, M., Harcourt, G., Loughry, A., Klenerman, P. (2005). Preferential loss of IL-2-secreting CD4+ T helper cells in chronic HCV infection. Hepatology, 41:1019-1028.
50. Shoukry, N. H., Grakoui, A., Houghton, M., Chien, D. Y., Ghrayeb, J., Reimann, K. A., Walker, C. M. (2003). Memory CD8+ T cells are required for protection from persistent hepatitis C virus infection. Journal of Experimental Medicine, 197:1645-1655.
51. Sugimoto, K., Ikeda, F., Stadanlick, J., Nunes, F. A., Alter, H. J., Chang, K. M. (2003). Suppression of HCV-specific T cells without differential hierarchy demonstrated ex vivo in persistent HCV infection. Hepatology, 38:1437-1448.
52. Tam, R. C., Pai, B., Bard, J., Lim, C., Averett, D. R., Phan, U. T., Milovanovic, T. (1999). Ribavirin polarizes human T cell responses towards a type 1 cytokine profile. Journal of Hepatology, 30:376-382.
53. Tang, K. H., Herrmann, E., Cooksley, H., Tatman, N., Chokshi, S., Williams, R., Zeuzem, S., Naoumov, N. V. (2005). Relationship between early HCV kinetics and T-cell reactivity in chronic hepatitis C genotype 1 during peginterferon and ribavirin therapy. Journal of Hepatology, 43:776-782.
54. Thursz, M., Yallop, R., Goldin, R., Trepo, C., Thomas, H. C. (1999). Influence of MHC class II genotype on outcome of infection with hepatitis C virus. The HENCORE group. Hepatitis C European Network for Cooperative Research. Lancet, 354:2119-2124.
55. Timm, J., Lauer, G. M., Kavanagh, D. G., Sheridan, I., Kim, A. Y., Lucas, M., Pillay, T., Ouchi, K., Reyor, L. L., Zur Wiesch, J. S., Gandhi, R. T., Chung, R. T., Bhardwaj, N., Klenerman, P., Walker, B. D., Allen, B. M. (2004). CD8 epitope escape and reversion in acute HCV infection. Journal of Experimental Medicine, 200:1593-1604.
56. Vertuani, S., Bazzaro, M., Gualandi, G., Micheletti, F., Marastoni, M., Fortini, C., Canella, A., Marino, M., Tomatis, R., Traniello, S., Gavioli, R. (2002). Effect of interferon-alpha therapy on epitope-specific cytotoxic T lymphocyte responses in hepatitis C virus-infected individuals. European Journal of Immunology, 32:144-54.
57. Ward, S., Lauer, G., Isba, R., Walker, B., Klenerman, P. (2002). Cellular immune responses against hepatitis C virus: the evidence base. Clinical & Experimental Immunology 128:195-203.
58. Wedemeyer, H., He, X. S., Nascimbeni, M., Davis, A. R., Greenberg, H. B., Hoofnagle, J. H., Liang, T. J., Alter, H., Rehermann, B. (2002). Impaired effector function of hepatitis C virus-specific CD8+ T cells in chronic hepatitis C virus infection. Journal of Immunology, 169:3447-3458.
59. Wherry, E. J., Ahmed, R. (2004). Memory CD8 T-cell differentiation during viral infection. Journal of Virology, 78:5535-5545.
60. Zafiropoulos, A., Barnes, E., Piggott, C., Klenerman, P. (2004). Analysis of "driver" and "passenger" CD8+ T-cell responses against variable viruses. Proceedings of the Royal Society B: Biological Sciences 271 Suppl. 3:S53-536.